Haiyang Yun was born in Henan, P.R.China in 1983. He holds a Bachelor’s Degree in Clinical Medicine from Tongji University (China, 2000-2005) and a Master’s Degree in Internal Medicine from Shanghai Jiao Tong University (China, 2005-2008). He enrolled in the Molecular Medicine PhD program at Hannover Medical School in Germany, and completed his doctoral thesis under the supervision of Prof. Michael Heuser in 2013. Subsequently Dr. Yun joined Prof. Brian Huntly’s lab at University of Cambridge, being a Postdoc Researcher from 2014 to 2018 to investigate high dimensional chromatin remodelling dynamics during leukemia evolution. Afterwards he returned to Germany and later became a Senior Scientist in the department led by Prof. Carsten Müller-Tidow at University Hospital Heidelberg. In Heidelberg he initiated and led a new project to identify chromatin-associated RNA molecules with essential roles in leukemia maintenance. Dr. Yun was promoted to a Group Leader position in the same department shortly after he acquired DFG research funding with the module “Temporary Positions for Principal Investigators” in 2022. Since then he has led a team to identify enhancer RNAs functioning on transcriptional regulation via chromatin modulation in leukemia. In January 2024, Dr. Yun assumed the independent Group Leader position at Robert the Robert Bosch Center for Tumor Diseases. His new role will be dedicated to the research on decoding complex functional epigenomics in hematological malignancies.
Relevant own publications
See more on ORCID